GMO: Capturing Domestic Demand in Emerging Markets: Neither Small Caps nor Multinationals Are a Good Proxy - By Arjun Divecha
Money and Finance

GMO: Capturing Domestic Demand in Emerging Markets: Neither Small Caps nor Multinationals Are a Good Proxy - By Arjun Divecha


As a complement to his article published in the FT on Jan. 4, Arjun Divecha fleshes out more fully his argument that buying emerging small cap stocks or large multinationals is not the best way to tap into domestic demand in emerging markets.

.....

Excerpt:

We believe one of the most compelling investment opportunities over the next few years is likely to be in companies that serve domestic demand within emerging markets. Our case rests on two underlying and interconnected forces – one economic and the other demographic. As poor countries get richer, they save as much as they can. Savings rates usually rise until countries reach a range of $3,000 to $10,000 per capita GDP. Once in that range, savings rates begin to decline and consumption becomes a larger part of GDP growth as society starts to provide a social safety net. At this level of wealth, per capita consumption of all goods and services rises in a highly non-linear fashion. For example, while Chinese per capita GDP quadrupled from $1,000 to $4,000 during the past decade, auto sales rose from one million vehicles per year to over 17 million. Markets rarely anticipate this kind of non-linear growth.

Fifty percent of all emerging markets (by market capitalization) are now in this sweet spot of shifting from savings to consumption.

Further strengthening the economic case is a shift in demographics: a record number of people are coming into their earning years in emerging markets at the same time that baby boomers are starting to retire in the developed world. As a result, we believe that the world is in the midst of a massive shift in demand from the developed world to emerging markets.

As this domestic demand play gains momentum, we hear increasingly that the best way to capture this theme is to buy small cap emerging stocks. We believe, however, that this is a mistake and that focusing on companies that specifically serve domestic demand is a more effective way to exploit the opportunity. Besides, why buy a proxy when you can buy the real thing?





- Morningstar Q&a With Ben Inker
Inker: The behavior of corporate profits in the U.S. for the last 10 or 15 years is weird. It doesn't follow a standard capitalist script. If you've got a situation where there is a very high return on capital, which there has been on average...

- Does The Shiller-pe Work In Emerging Markets?
Found via Mebane Faber. We test the reliability of the Cyclically Adjusted PE (CAPE) or Shiller PE as a forecasting and valuation tool for 35 countries including emerging markets. We find that the Shiller-PE is a reliable long-term valuation indicator...

- John Mauldin's Outside The Box: The Geopolitics Of Brazil
Just last week in Thoughts from the Frontline, we discussed the relative valuations of emerging markets. Any discussion of an emerging market is incomplete without understanding the underlying geopolitical forces that guide behaviors of countries and...

- Recent Buy
Well I just couldn't help myself this past Friday and made another purchase.  It wasn't that long ago that I had doubled up my position in PepsiCo, February 14th to be exact but the price continued to decline so I added some more.  I was fairly...

- How Do You Solve A Problem Like Emerging?
That was fast - Emerging Markets went from everyone's darling to everyone's whipping boy. One of the main points of agreement for the last five years or so is that maybe the US would struggle, maybe Europe would struggle but Emerging Markets would...



Money and Finance








.